Breast Cancer
NCI publishes statement on mammography screening
Published in Cancer Weekly, March 5th, 2002
A recent report in the scientific literature has reawakened debate about the value of screening mammograms. The analysis, which appeared in the Lancet on October 20, 2001, reviewed the large, long-term mammography trials upon which the National Cancer Institute (NCI) and other groups have based their recommendations and guidelines concerning mammography screening. This review cited a number of possible flaws in the conduct of the trials and the methods used to analyze the data.
The NCI has carefully considered the issues raised in the Lancet review. It has also considered the recent deliberations of the PDQ Screening and Prevention Editorial Board and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2002-03-05)
More Articles from Cancer Weekly
- Cancer Therapy
Retinoic acid might be of more harm than benefit to cancer patients - Leukemia
Tumor suppressor genes can block leukemic cell proliferation - Diagnostic Imaging
Contrast agent improves some aspects of visualizing tumor vascularity - Non-Hodgkin Lymphoma
Autologous stem cell grafts alter Th1/Th2 balance - Tumor Factors
Reduced levels of extracellular enzyme may actually promote cancer growth - Uveitis
Cancer-causing drug safe and effective in treating eye disease - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
